Pegasys - 0004-0350-09 - (peginterferon alfa-2a)

Alphabetical Index


Drug Information of Pegasys

Product NDC: 0004-0350
Proprietary Name: Pegasys
Non Proprietary Name: peginterferon alfa-2a
Active Ingredient(s): 180    ug/mL & nbsp;   peginterferon alfa-2a
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Pegasys

Product NDC: 0004-0350
Labeler Name: Genentech, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103964
Marketing Category: BLA
Start Marketing Date: 20021016

Package Information of Pegasys

Package NDC: 0004-0350-09
Package Description: 1 VIAL, SINGLE-USE in 1 BOX (0004-0350-09) > 1 mL in 1 VIAL, SINGLE-USE

NDC Information of Pegasys

NDC Code 0004-0350-09
Proprietary Name Pegasys
Package Description 1 VIAL, SINGLE-USE in 1 BOX (0004-0350-09) > 1 mL in 1 VIAL, SINGLE-USE
Product NDC 0004-0350
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name peginterferon alfa-2a
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20021016
Marketing Category Name BLA
Labeler Name Genentech, Inc.
Substance Name PEGINTERFERON ALFA-2A
Strength Number 180
Strength Unit ug/mL
Pharmaceutical Classes Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient]

Complete Information of Pegasys


General Information